HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A clinical study to determine the efficacy and safety of 1% methotrexate/Azone (MAZ) gel applied topically once daily in patients with psoriasis vulgaris.

AuthorsL Sutton, J M Swinehart, A Cato, A S Kaplan
JournalInternational journal of dermatology (Int J Dermatol) Vol. 40 Issue 7 Pg. 464-7 (Jul 2001) ISSN: 0011-9059 [Print] England
PMID11679005 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Dermatologic Agents
  • Gels
  • Methotrexate
Topics
  • Administration, Cutaneous
  • Adult
  • Aged
  • Dermatologic Agents (adverse effects, therapeutic use)
  • Double-Blind Method
  • Female
  • Gels
  • Headache (chemically induced)
  • Humans
  • Male
  • Methotrexate (adverse effects, therapeutic use)
  • Middle Aged
  • Pruritus (chemically induced)
  • Psoriasis (drug therapy, pathology)
  • Severity of Illness Index
  • Skin (drug effects, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: